ISAL 2023 | QoL, life satisfaction, and anxiety & depression symptoms in AML long-term survivors
Eva Telzerow, MSc, Ludwig-Maximilians University, Munich, Germany, shares the results of the AMLCG-survivorship study which evaluated somatic and psycho-social outcomes in long-term survivors of acute myeloid leukemia (AML). The study reported that quality of life (QoL) and health-related life satisfaction were similar to that of the general population. However, general life satisfaction of AML long-term survivors appeared to be impacted by a different set of factors. High rates of anxiety and depression were reported among a subset of patients, particularly those with lower incomes, suggesting a need for targeted interventions. This interview took place at the 18th International Symposium on Acute Leukemias (ISAL XVIII), held in Munich, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
